Our poster on the transition zone between motor and cognitive function in Long Covid, Parkinson’s and Alzheimer’s disease patients was published at AAIC 21 (26 - 31/07/21) in Denver, Colorado, USA.

A new EEG biomarker, the Frontal Asymmetry Index (FAI), was presented that can be used to clearly distinguish between Alzheimer’s disease patients and control subjects.

Furthermore, first results of 40 Hz neurostimulation in a Long COVID patient suffering from tremor and chronic fatigue syndrome were presented.

The first results justify the statement that sensory neurostimulation at 40 Hz can eliminate the pathological peaks at 20 Hz typical of tremor and Parkinson’s disease. The durability of this effect as well as the transferability to Alzheimer’s disease are currently being investigated.

Files:

• Poster presentation (MP4, 1920×1080 px, 5,2 MB)
• Slides (PDF, 10,8 MB)
• Abstract (PDF, 353 KB)
• Transcript (PDF, 66 KB)
• Questions and answers (PDF, 141 KB)